Back to top

Pfizer Advances New Obesity Shot With Early Stage Trial of PF-08653945

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. is launching a Phase 1 study titled “A Phase 1, Open-Label, Rand...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Pfizer Inc. (PFE)